There are more than one billion people living under $1.25 a day and almost the same number playing at least one hour of video games worldwide. So, how can the popularity of games be harnessed for positive social change?

Countries such as Barbados are facing legal and ethical obstacles to develop effective regulatory mechanisms for the emerging medical tourism sector.

As mobile health technologies become prevalent there is a need to make sure they are effective and safe, but also to understand the implications for individuals and communities.

Online tools such as Audiovisual Translation (AVT) and Assistive Technology (AST) have the potential to aid the provision of university-level educational material for people with sensory impairments such as blindness and deafness.

From improving the process of food production to keeping up with the demands of a rising population, to developing novel and sophisticated biological treatments for life-threatening diseases, biotech can and does impact multiple aspects of our life.

Metabonomics, namely the observation of small molecules within a biological sample, has emerged as a new potential treatment due to the complexity of mainstream genetic and biomedical research.

The hand is a crucial part of the body, and the desire to replace it following an amputation – with trauma or cancer being the main underlying causes – is a natural one. Existing bionic hands are already good substitutes for the natural limb yet a number of limitations prevail.

While remains a widespread view that cancer only affects those in wealthier regions of the world and the elderly, at least half of cancers are diagnosed today in developing countries and these carry the greatest burden of premature mortality from cancer.

Research based at Imperial College in the area of Popeye domain containing aims to provide a novel insight into the ageing process and potentially provide new therapeutic opportunities to help the ageing heart.

Better co-ordinating care, improving the flow of patient information and ensuring that adequate funding mechanisms are in place are crucial if societies are to deal with the challenges posed by ageing societies.

Effectively launching a new biopharma product, however, has never been more challenging. In addition to a litany of regulatory issues, companies face high stakeholder expectations, numerous market-access hurdles, and stiff competition, all of which are made more formidable by the business realities of the industry.

All the heroic ambitions for improving global health must confront the prosaic reality of finding the necessary financial resources.

This article examines why drug resistant TB has come into existence, how it can be categorized, what treatment options are available and how the global health community plans to combat this growing threat.

Governments faced with rising costs and growing demand are constantly searching for methods of delivering better healthcare. Reforms which promote competition are currently very much in vogue, yet while the political appeal is simple critics argue that the features of healthcare make the use of competition inappropriate.

Never far from the media spotlight has been the mental health of those presently serving in the armed forces, those who have served (veterans), as well as the wider military community.

The majority of antibiotic use is in the community, however the impact of antibiotic resistance is felt most acutely when treating patients in healthcare settings.